- Our Team
- For Patients
- Treatments & Services
- Medical Professionals
Clinical Trial
Clinical Trial Search
Trial Protocol ID USOR 23059_CO44657
Trial Description
A PHASE III RANDOMIZED, OPEN-LABEL STUDY EVALUATING EFFICACY AND SAFETY OF GIREDESTRANT COMPARED WITH FULVESTRANT, BOTH COMBINED WITH A CDK4/6 INHIBITOR, IN PATIENTS WITH ESTROGEN RECEPTOR-POSITIVE, HER2-NEGATIVE ADVANCED BREAST CANCER WITH RESISTANCE TO PRIOR ADJUVANT ENDOCRINE THERAPY
Contact us regarding Clinical Trials at MOHRSCH@usoncology.com or call us at 877-664-7724
Investigator
- Carol Tweed, MD
Disease Types
Sponsor
- F. Hoffmann-La Roche Ltd
ClinicalTrials.gov NCT ID
- NCT06065748